|
Valoración de DCF de Nucana PLC (NCNA)
GB | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
NuCana plc (NCNA) Bundle
¿Busca determinar el valor intrínseco de Nucana PLC? Nuestra calculadora DCF (NCNA) integra datos del mundo real con extensas características de personalización, lo que le permite ajustar los pronósticos y mejorar sus estrategias de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | .0 | .0 | .0 | -65.3 | -36.2 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .0 | 1.1 | 1.2 | .9 | .7 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | .0 | -1.1 | -1.2 | -66.2 | -36.9 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 65.0 | 109.3 | 75.4 | 52.4 | 21.6 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | 7.3 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 3.0 | 2.8 | 2.3 | 6.0 | 4.2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -1.6 | -2.0 | -1.3 | -.6 | -.6 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 13.73 | 13.73 | 13.73 | 13.73 | 13.73 | 13.73 | 13.73 | 13.73 | 13.73 | 13.73 |
| EBITAT | .0 | -.9 | -1.0 | -55.1 | -31.8 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 1.5 | -2.1 | -1.7 | -51.1 | -40.8 | 3.1 | .0 | .0 | .0 | .0 |
| WACC, % | 41.06 | 41.59 | 41.58 | 40.98 | 42.16 | 41.47 | 41.47 | 41.47 | 41.47 | 41.47 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 2.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 2 | |||||||||
| Net Debt | -21 | |||||||||
| Equity Value | 23 | |||||||||
| Diluted Shares Outstanding, MM | 2 | |||||||||
| Equity Value Per Share | 11.02 |
What You Will Get
- Comprehensive NCNA Financials: Access to historical and projected data for precise valuation.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess NuCana's future performance.
- User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.
Key Features
- Customizable Clinical Parameters: Adjust key metrics such as trial phases, patient demographics, and treatment regimens.
- Instant DCF Analysis: Provides immediate calculations of intrinsic value, NPV, and other financial metrics.
- High Precision Results: Utilizes NuCana plc's (NCNA) actual financial data for accurate valuation assessments.
- Simplified Scenario Testing: Easily evaluate various hypotheses and analyze results side-by-side.
- Efficiency Booster: Removes the necessity of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for NuCana plc (NCNA).
- Step 2: Review NuCana’s pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and leverage the results for your investment decisions.
Why Choose This Calculator for NuCana plc (NCNA)?
- User-Friendly Interface: Tailored for both novice and experienced users.
- Customizable Inputs: Adjust parameters to accurately represent your financial analysis.
- Real-Time Feedback: Observe immediate updates to NuCana's valuation as you change inputs.
- Preloaded Data: Comes with NuCana's actual financial metrics for efficient evaluation.
- Relied Upon by Experts: Utilized by analysts and investors for strategic decision-making.
Who Should Use This Product?
- Pharmaceutical Students: Understand drug development processes and apply them using real-world case studies.
- Researchers: Utilize advanced models for analyzing clinical trial data and outcomes.
- Investors: Evaluate your investment strategies and assess the potential of NuCana plc (NCNA) stock.
- Market Analysts: Enhance your analysis with a customizable model tailored for biotech companies.
- Healthcare Professionals: Gain insights into how innovative biotech firms like NuCana plc (NCNA) are assessed in the market.
What the Template Contains
- Pre-Filled Data: Contains NuCana plc's historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations for ease of use.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC using custom inputs.
- Key Financial Ratios: Evaluate NuCana plc's profitability, efficiency, and leverage metrics.
- Customizable Inputs: Easily modify revenue growth, margins, and tax rates as needed.
- Clear Dashboard: Visual representations such as charts and tables summarizing essential valuation outcomes.